New diabetes clinical trial: A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)

Published on: May 15, 2019 at 09:30PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Tirzepatide;   Drug: Semaglutide;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Not yet recruiting
http://bit.ly/2LFU5Bb